We are delighted to announce that the Bibsam Consortium has signed a Read & Publish agreement covering all seven of the Biochemical Society’s journals, supporting authors at participating institutions to publish open access (OA) across the full breadth of the molecular biosciences.  

The agreement enables affiliated corresponding authors at participating Swedish institutions to publish an unlimited number of articles, fee-free and OA, in addition to providing full read access to our current portfolio.

The Karolinska Institute, KTH Royal Institute of Technology, Lund University, Umeå University, and Uppsala University join more than 200 institutions around the world currently signed up to our Read & Publish offering and the Bibsam agreement enables more Swedish institutions to opt-in during 2023.

The agreement represents another important step in the Society’s transition to full OA publishing, supporting the shared mission of like-minded research institutions and not-for-profit publishers to accelerate the shift towards the sustainable and open dissemination of research on a global scale.

Anna Lundén, Director of the Department for Collaboration at the National Library of Sweden, says: 

"We are excited to sign a transformative agreement with Portland Press. The Biochemical Society’s journals are in high demand by Swedish researchers, so this is a welcome addition to the Bibsam Consortium portfolio of transformative agreements advancing open science."

Institutions signed up under this agreement for 2023:

• Karolinska Institute
• KTH Royal Institute of Technology
• Lund University
• Umeå University
• Uppsala University
  
  

All Biochemical Society journals are included:

• Biochemical Journal
• Clinical Science
• Bioscience Reports (OA)
• Neuronal Signaling (OA)
• Biochemical Society Transactions
• Essays in Biochemistry
• Emerging Topics in Life Sciences (co-owned with the Royal Society of Biology)

About the Biochemical Society

The Biochemical Society works in partnership with researchers, institutions, and funders to share knowledge and advance the molecular biosciences. Publishing world-leading research and reviews across a portfolio of seven journals, we return all profits to the life science community in support of our charitable activities.

We’re committed to a sustainable transition to a more open scholarly publishing landscape and our Read & Publish initiative builds on the principles set out in our Open Scholarship position statement. Portland Press is the wholly-owned publishing arm of the Biochemical Society.